Practical guides on Google Merchant Center suspensions, Google Ads policy, Shopping feeds, email marketing and compliant growth for research peptide, supplement and other regulated e-commerce brands. Every article is written from real reinstatement casework by the iComChain team.
Expanding a US peptide or supplement store to the UK and EU? MHRA’s position, the medicinal-product tests, Merchant Center country settings and policy pages.
Suspended again after failed appeals? How to rebuild credibility with Google, the evidence pack to prepare, the appeal structure that works, and when to stop.
Google launched Shopping ads in AI Mode in 2026. What’s known, what isn’t, how policies apply to supplement and peptide brands, and how to ready your feed.
Why semaglutide, tirzepatide and retatrutide listings trigger Merchant Center suspensions, what FDA’s 2026 letters added, and the certified routes that work.
FDA’s advisory panel backed six peptides incl. BPC-157 and TB-500 for compounding in July 2026. What changes, what doesn’t, and what it means for Google Ads.
What Google Ads management costs for peptide, supplement and regulated brands in 2026: % of spend vs flat fee, real examples, and what the fee should include.
Cheap Merchant Center reinstatement gigs often use new accounts, new domains or mass appeals. Why that triggers permanent bans and what a real fix takes.
Stripe, PayPal or Shopify Payments shut down your peptide store? Held funds, the 72-hour plan, and why your next processor affects Google approval.
The 2026 FDA peptide warning letters were built from website content. The 10 elements FDA cited and what genuine research-supply positioning looks like.
Got an FDA warning letter for your peptide site? What the 2026 letters cited, the 15-business-day response, and the impact on Google Ads and payments.